Venentoclax

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Venentoclax trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 2 trials

RecruitingPhase 3

NCT07396480

Fludarabine Plus Melphalan Versus Addition of Venetoclax to Fludarabine/Melphalan Conditioning Regimen for Allogeneic He…

Allogeneic Hematopoietic Cell Transplantation (Allo-HCT) serves as a curative treatment modality for the vast majority of patients with hematological malignanci…

China186 participantsStarted 2026-03-01

Treatment: Venetoclax in combination with fludarabine and melphalan, Fludarabine and Melphalan

RecruitingNot Applicable

NCT06256627

The Maintenance Treatment of "ITIVA" in AML Patients

We apply for this clinical study to evaluate the efficacy of "combined recombinant human interference'- α- 1b, interleukin-2, and thalidomide" regimen in obtain…

China130 participantsStarted 2023-07-11

Treatment: recombinant human interference'- α- 1b, interleukin-2, thalidomide, Venentoclax and Azacitidine

All recent trials (3 shown)

Not Yet RecruitingPhase 2

NCT07425782

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

The goal of this clinical trial is to compare the efficacy and safety of a venetoclax-based consolidation therapy versus conventional consolidation chemotherapy…

Location not specified216 participantsStarted 2026-02-01

Treatment: Ara-C Group, VEN/AZA condsolidation